SCHEMBL31351306

SCHEMBL31351306

CN(C)CCn1ncc2cc(N)c(-c3ccsc3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1D P28221 1/20 0.44
▸ KDR P35968 3/20 0.42
▸ EGFR P00533 4/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ CHEK2 O96017 1/20 0.37
▸ FLT1 P17948 1/20 0.37
▸ FLT4 P35916 1/20 0.37
▸ KCNH2 Q12809 1/20 0.35
▸ MCHR1 Q99705 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ TDO2 P48775 1/20 0.34
▸ RAB9A P51151 2/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ EPHX2 P34913 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ BTK Q06187 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31351081 0.82 CYP2A6 (0.36) KDRCYP2A6CHEK2GAATDO2
SCHEMBL7253008 0.81 HTR1D (0.62) HTR1DKDREGFRCYP2A6CHEK2
SCHEMBL31351105 0.80 CARM1 (0.40) EGFRKCNH2MCHR1MAP4K4TGFBR1
SCHEMBL31350907 0.75 HTR1D (0.41) HTR1DKDRCYP2A6CHEK2FLT1
SCHEMBL7258088 0.74 HTR1D (0.57) HTR1DKDRCHEK2FLT1FLT4
SCHEMBL16741876 0.73 EGFR (0.42) EGFRKCNH2MCHR1
SCHEMBL31350911 0.72 IRAK4 (0.41) RAB9APOLBNPC1
SCHEMBL6070377 0.71 CHEK1 (0.47) EGFRKCNH2MCHR1
SCHEMBL29533972 0.71 CHEK1 (0.47) EGFRKCNH2MCHR1
SCHEMBL6070011 0.71 HTR2A (0.47) HTR1DEGFRKCNH2MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025003987-A1 NOVEL CARBOXAMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 동화약품주식회사 2025-01-02 — — WO disclosed
Send feedback